The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein-2: A review of 200 patients

Journal of Neurosurgery: Spine

Volumn 8, Issue 6, 2008, Pages 529-535

  Tumialán, Luis M ^a   Pan, Jeff ^b   Rodts Jr , Gerald E ^a   Mummaneni, Praveen V ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of California San Francisco Spine Center ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anterior cervical discectomy and fusion; Bone morphogenetic protein; Polyetheretherketone

Indexed keywords

COLLAGEN TYPE 1; KETONE DERIVATIVE; POLYETHERETHERKETONE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TITANIUM;

ADULT; AGED; ANTERIOR CERVICAL DISCECTOMY AND FUSION; ARTICLE; BONE PLATE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG MECHANISM; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PLATE FIXATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; SCORING SYSTEM; SPINAL CORD DISEASE; SPINE FUSION; SPINE RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; BONE PLATES; CERVICAL VERTEBRAE; COLLAGEN TYPE I; DEGLUTITION DISORDERS; DISKECTOMY; DRUG CARRIERS; FEMALE; FOLLOW-UP STUDIES; HEMATOMA; HUMANS; KETONES; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ORTHOPEDIC FIXATION DEVICES; POLYETHYLENE GLYCOLS; POSTOPERATIVE COMPLICATIONS; RANGE OF MOTION, ARTICULAR; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SAFETY; SEROMA; SPINAL FUSION; TITANIUM; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 45149108605     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/SPI/2008/8/6/529     Document Type: Article

References (22)

1. Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA: A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 28:1219-1225, 2003
2. Bazaz R, Lee MJ, Yoo JU: Incidence of dysphagia after anterior cervical spine surgery: a prospective study. Spine 27:2453-2458, 2002
3. Bennett M, Reynolds AS, Dickerman RD: Recent article by Shields et al titled "adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion". Spine 31:2029-2030, 2006 (Letter)
4. Boakye M, Mummaneni PV, Garrett M, Rodts G, Haid R: Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg Spine 2:521-525, 2005
5. Boden SD, Zdeblick TA, Sandhu HS, Heim SE: The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25:376-381, 2000
6. Burkus JK: Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 1: 254-260, 2004
7. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA: Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15:337-349, 2002
8. Burkus JK, Heim SE, Gornet MF, Zdeblick TA: The effectiveness of rhBMP-2 in replacing autograft: an integrated analysis of three human spine studies. Orthopedics 27:723-728, 2004
9. Burkus JK, Sandhu HS, Gornet MF: Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft. Spine 31:775-781, 2006
10. Carlisle E, Fischgrund JS: Bone morphogenetic proteins for spinal fusion. Spine J 5 (6 Suppl):240S-249S, 2005
11. Fischgrund JS, James SB, Chabot MC, Hankin R, Herkowitz HN, Wozney JM, et al: Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord 10:467-472, 1997
12. Giannoudis PV, Dinopoulos H, Tsiridis E: Bone substitutes: an update. Injury 36 (3 Suppl):S20-S27, 2005
13. Heary RF, Schlenk RP, Sacchieri TA, Barone D, Brotea C: Persistent iliac crest donor site pain: independent outcome assessment. Neurosurgery 50:510-517, 2002
14. Lanman TH, Hopkins TJ: Early findings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein-2 was used with poly(L-lactide-co-D, L-lactide) bioabsorbable implants. Neurosurg Focus 16(3):E6, 2004
15. Nurick S: The natural history and the results of surgical treatment of the spinal cord disorder associated with cervical spondylosis. Brain 95:101-108, 1972
16. Odom GL, Finney W, Woodhall B: Cervical disk lesions. JAMA 166:23-28, 1958
17. Patel VV, Zhao L, Wong P, Kanim L, Bae HW, Pradhan BB, et al: Controlling bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth using fibrin glue. Spine 31:1201-1206, 2006
18. Perri B, Cooper M, Lauryssen C, Anand N: Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 7:235-239, 2007
19. Samartzis D, Shen FH, Goldberg EJ, An HS: Is autograft the gold standard in achieving radiographic fusion in one-level anterior cervical discectomy and fusion with rigid anterior plate fixation? Spine 30:1756-1761, 2005
20. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, et al: Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31:542-547, 2006
21. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG: Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31:2813-2819, 2006
22. Tomford WW: Bone allografts: past, present and future. Cell Tissue Bank 1:105-109, 2000